Showing results (851-860 of 926) with videos related to
Sort By:
Pageof 93
Nature Structural & Molecular Biology|June 19, 2024
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsantsAnshumali Mittal, Matthew F Martin, Elena J Levin, et al.Diagnostic Microbiology and Infectious Disease|August 29, 2003
Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruziAlejandro O Luquetti, Carlos Ponce, Elisa Ponce, et al.The Journal of Pain|September 1, 2004
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventoryPaul M Coplan, Kenneth Schmader, Alexander Nikas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2015
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral TherapyGayatri Mirani, Paige L Williams, Miriam Chernoff, et al.Antiviral Research|January 1, 1997
Assessment of pain in herpes zoster: lessons learned from antiviral trialsR H Dworkin, D Carrington, A Cunningham, et al.Journal of Neurovirology|July 23, 2005
Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblastsScott A Simpson, Michael D Manchak, Elizabeth J Hager, et al.Journal of Clinical Microbiology|October 7, 2005
Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central AmericaCarlos Ponce, Elisa Ponce, Elizabeth Vinelli, et al.Current Eye Research|February 1, 2021
Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year PeriodMaitri Pancholy, Philip P Storey, Hannah J Levin, et al.The Lancet. Infectious Diseases|April 11, 2016
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trialChan R Beals, Radha A Railkar, Andrea K Schaeffer, et al.Journal of the American Geriatrics Society|September 25, 2010
Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adultsKenneth E Schmader, Gary R Johnson, Patricia Saddier, et al.Pageof 93